Aldeyra Therapeutics Reports Second-Quarter 2021 Financial Results and Recent Corporate Highlights

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. MU
3. SPCX
4. ACN
5. IBM
6. TSLA
7. DPZ
8. NVDA
9. PRIM
10. META

Go back to Aldeyra Therapeutics Reports Second-Quarter 2021 Financial Results and Recent Corporate Highlights

Aldeyra Therapeutics (ALDX) Misses Q2 EPS by 4c

August 5, 2021 7:51 AM EDT

Aldeyra Therapeutics (NASDAQ: ALDX) reported Q2 EPS of ($0.28), $0.04 worse than the analyst estimate of ($0.24).


For earnings history and earnings-related data on Aldeyra Therapeutics (ALDX) click here.

... More